LifebankUSA(TM) Announces New Service to Bank Placental-Derived Stem Cells
LifebankUSA, a subsidiary of Celgene Cellular Therapeutics (CCT), announced plans for a new service to bank stem cells derived from the placenta. Placental-derived stem cells (PDSCs), which have different characteristics from those isolated from cord blood, appear to be highly versatile and have the potential to repair damaged or diseased tissue. In the laboratory, CCT scientists have successfully developed nerve cells, heart cells, cartilage cells, bone cells, and other highly specialized cells from pluripotent stem cells derived from the placenta.
The new Placental-Derived Stem Cell Storage Service will begin on April 24th.
Organizations
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.